NCT05325879

Brief Summary

The increase in the tension of the soft tissues around a nerve restricts the movement, affects the function of the nerve, and makes the nerve vulnerable to entrapment. Even a mild nerve compression can cause entrapment and lead to neuroinflammation. It is known that inflammatory mediators amplify axonal sensitivity. Although the spontaneous discharge potential of visceral afferents is quite low under normal conditions, neuroinflammation increases the excitability of these fibers. With this mechanism, hyperalgesia may develop in sensory fibers in neuroinflammation. This may cause pathologies in the organs innervated by the relevant nerve. The fascia and muscles of the cervical region surround the vagus nerve. There are two main fascial compartments in the cervical region. The SCM and trapezius muscle fascias join to the most superficial fascia of the deep cervical fascia and they together form these compartments. These fasciae superiorly attach to the cranium and inferiorly to the pectoral region. The vagus nerve emerges from the jugular foramen together with the 9th and 11th cranial nerves. It then continues through the carotid sheath in the cervical region. The carotid sheath is in contact with the SCM muscle. For this reason, it can be thought that SCM muscle tension or thickness may affect the carotid sheath and thus the function of the vagus nerve passing through it. In summary, deterioration in vagus nerve activity plays a role in pathologies of the organs innervated by the vagus. Although the relationship between vagal dysfunction and gastrointestinal system symptoms is clear, the mechanisms affecting vagus nerve function have not yet been clarified. It has been reported in the literature that some maneuvers from the cervical region are also effective on the vagus nerve. Also, according to investigators' clinical experience, gastrointestinal symptoms are frequently observed in patients with increased cervical soft tissue tension. However, there are not enough studies investigating whether the cervical region soft tissue tension can affect the gastrointestinal system via the vagus nerve. Therefore, this study was planned to examine the relationship of cervical soft tissue tension with vagus nerve function and gastrointestinal symptoms in asymptomatic individuals and individuals with neck pain.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
41

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Aug 2022

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

April 6, 2022

Completed
7 days until next milestone

First Posted

Study publicly available on registry

April 13, 2022

Completed
4 months until next milestone

Study Start

First participant enrolled

August 15, 2022

Completed
1.1 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 15, 2023

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

September 15, 2023

Completed
Last Updated

November 18, 2023

Status Verified

November 1, 2023

Enrollment Period

1.1 years

First QC Date

April 6, 2022

Last Update Submit

November 16, 2023

Conditions

Keywords

vagus nervemuscle tonusAutonomic Nervous System DiseasesPain Threshold

Outcome Measures

Primary Outcomes (3)

  • Evaluation of Vagal Function

    Vagus nerve function will be evaluated with the Vagus Neurodynamic Test (VAGUS-NDT). Carta et al. VAGUS-NDT, which was validated and reliable in 2020, evaluates vagal function selectively. The test is performed with the patient in the supine position. The test is considered positive if unpleasant sensations are described when pressure is applied to the abdomen after the head is placed in cervicocranial flexion, lateral flexion, and rotation.

    10 minutes, in one assessment session

  • Evaluation of SCM Muscle Tension

    SCM muscle tension will be performed with Myoton-3 (Muomeetria AS, Tallinn, Estonia) myometer. Myometer is a high validity and reliability method used to evaluate muscle tension. During the measurement, the device will give the tension of the muscle numerically by making a light touch on the skin. For the measurement, the myotone will be placed perpendicular to the midpoint between the anterior surface of the manubrium sterni and the mastoid process of the temporal bone, and an average of 10 measurements will be used.

    10 minutes, in one assessment session.

  • Hospital Anxiety and Depression Scale

    Hospital Anxiety and Depression Scale was developed by Zigmond and Snaith, and the Turkish version of the scale was published by Aydemir et al. The scale consists of 14 items, 7 of which assess anxiety and 7 of which assess depression symptoms. It is a 4-point Likert scale type and is scored between 0-3. A high score indicates high levels of anxiety and depression

    10 minutes, in one assessment session

Secondary Outcomes (3)

  • Evaluation of Neck Disability

    5 minutes, in one assessment session.

  • Evaluation of Pain Intensity

    1 minutes, in one assessment session.

  • Evaluation of Gastrointestinal Symptoms

    5 minutes, in one assessment session.

Study Arms (2)

Asymptomatic Individuals

ACTIVE COMPARATOR

Individuals aged between 18-50 who volunteered to participate in the study, will form the control group.

Other: VAGUS-NDT

Individuals with neck pain

EXPERIMENTAL

Individuals with neck pain aged between 18-50 who volunteered to participate in the study, will form the study group.

Other: VAGUS-NDT

Interventions

Neurodynamic test for vagus nerve

Asymptomatic IndividualsIndividuals with neck pain

Eligibility Criteria

Age18 Years - 50 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may qualify if:

  • Being 18-50 of age,
  • Having less than 30 body mass index,
  • Being a volunteer

You may not qualify if:

  • Having any type of malign disease,
  • Being diagnosed with a systemic disease (cardiologic, gastrointestinal, rheumatological, neurological, etc.),
  • Having any type of surgery within the last 6 months,
  • Being diagnosed with Whiplash syndrome
  • Having an unhealed fracture
  • Pregnancy
  • Using prescribed medicine for the gastrointestinal system

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Yasemin Özel Aslıyüce

Ankara, Sıhhiye, 06100, Turkey (Türkiye)

Location

MeSH Terms

Conditions

Gastrointestinal DiseasesAutonomic Nervous System Diseases

Condition Hierarchy (Ancestors)

Digestive System DiseasesNervous System Diseases

Study Officials

  • Utku Berberoğlu, MSc

    Hacettepe University

    STUDY CHAIR
  • Özgün Uysal, MSc

    Hacettepe University

    STUDY CHAIR
  • Özlem Ülger, Professor

    Hacettepe University

    STUDY DIRECTOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NON RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Purpose
SCREENING
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Research Assistant

Study Record Dates

First Submitted

April 6, 2022

First Posted

April 13, 2022

Study Start

August 15, 2022

Primary Completion

September 15, 2023

Study Completion

September 15, 2023

Last Updated

November 18, 2023

Record last verified: 2023-11

Data Sharing

IPD Sharing
Will not share

Locations